NCT05949645View on ClinicalTrials.gov

Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

October 8, 2024

Study Completion Date

June 1, 2026

Conditions
Emphysema or COPD
Interventions
DEVICE

Apreo Implant Group

One or two procedures involving placement of up to three Apreo implants in the bronchial tree of each lung.

Trial Locations (3)

9713

University Medical Center Groningen, Groningen

Unknown

Karl Landsteiner Institute, Klinik Floridsdorf, Sankt Pölten

Royal Brompton Hospital, London

Sponsors

Lead Sponsor

Apreo Health, Inc.
All Listed Sponsors
lead

Apreo Health, Inc.

INDUSTRY